What does prepaid research and development costs mean?

This captures advance payments made to third-party research organizations, clinical trial sites, or suppliers for future R&D activities. It is a leading indicator of upcoming research intensity and the company's commitment to its drug development pipeline. Tracking this helps investors gauge the near-term velocity of R&D spending.

Rigel Pharmaceuticals RIGL Prepaid research and development costs

Prepaid research and development costs at other companies

Relmada Therapeutics, Inc.RLMD

$866.6K+226%

Immix Biopharma, Inc.IMMX

$1.23M+229%

Alumis Inc.ALMS

$3.35M-74.0%

Esperion TherapeuticsESPR

$5.79M+1,049%

Viking TherapeuticsVKTX

$4.02M-69.8%

Theravance BiopharmaTBPH

-$73K-252%

Other financials

Income statement

See full

Revenue$58.8M+10.3%

Gross profit$54.2M+10.8%

Operating income$11.9M-7.0%

Net income$8.7M-24.4%

EPS (diluted)$0.44-30.2%

Balance sheet

See full

Cash & equivalents$24.5M-46.6%

Total debt$68.4M+5,079%

Total equity$399.9M+2,054%

Total assets$504.6M+187%

Cash flow

See full

Operating cash flow$2.7M+405%

CapEx$73.0K—

Free cash flow-$22.0M—

Valuation

See full

Market cap$684.39M+102%

Enterprise value$728.29M+148%

P/E1.9×-7.2×

P/S2.3×+0.6×

Profitability

See full

Gross margin93.4%+3.7pp

Operating margin41.6%+19.9pp

Net margin121.5%+103pp

FCF margin-61.7%—

Returns & leverage

See full

Return on equity174.1%—

Debt / equity0.2×+0.1×

Current ratio2.6×+0.4×

Where this comes from

Reported directly by Rigel Pharmaceuticals in its filing.

Tagged under the XBRL concept rigl:PrepaidResearchAndDevelopmentCost.

The official record: Rigel Pharmaceuticals’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's prepaid research and development costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's prepaid research and development costs?: Rigel Pharmaceuticals (RIGL) reported prepaid research and development costs of $4.89M in Q4 2025.
What does prepaid research and development costs mean?: This captures advance payments made to third-party research organizations, clinical trial sites, or suppliers for future R&D activities. It is a leading indicator of upcoming research intensity and the company's commitment to its drug development pipeline. Tracking this helps investors gauge the near-term velocity of R&D spending.